Hypera S.A. (HYPMY)
OTCMKTS · Delayed Price · Currency is USD
4.600
+0.540 (13.30%)
At close: Jan 9, 2026
Hypera Market Cap
Hypera has a market cap or net worth of $2.78 billion as of January 9, 2026. Its market cap has increased by 56.65% in one year.
Market Cap
2.78B
Enterprise Value
4.18B
Revenue
1.31B
Ranking
n/a
PE Ratio
18.00
Stock Price
$4.60
Market Cap Chart
Since April 18, 2008, Hypera's market cap has increased from 1.59B to 2.78B, an increase of 75.30%. That is a compound annual growth rate of 3.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 2.78B | 2.91% |
| Dec 30, 2025 | 2.70B | 47.28% |
| Dec 30, 2024 | 1.84B | -60.72% |
| Dec 28, 2023 | 4.67B | -14.36% |
| Dec 29, 2022 | 5.46B | 70.31% |
| Dec 30, 2021 | 3.20B | -23.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 506.04M |
| Northwest Biotherapeutics | 405.74M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 352.88M |
| Silence Therapeutics | 273.96M |